Mark Wager is a pharmacist who is specialized in Ambulatory Care in Phoenix, Arizona. Patients can reach him at 9201 W Thomas Rd, Phoenix or contact him on 623-327-6170. Active license number of Mark Wager is I025269 for Ambulatory Care in Arizona. Mark Wager is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Mark Wager speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mark Wager
Specialization:
Ambulatory Care
Gender:
Male
Location:
9201 W Thomas Rd, Phoenix, Arizona, 85037-3332
Phone:
623-327-6170
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mark Wager are as mentioned below.
NPI Number:
1184403164
NPI Enumeration Date:
27 Sep, 2023
NPI Last Update On:
27 Sep, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mark Wager are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
I025269
Arizona
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
5421 S Southern Oak Dr, Tucson, Arizona
Zip:
85746-1345
Phone Number:
520-329-7563
Fax Number:
--
Patients can reach Mark Wager at 9201 W Thomas Rd, Phoenix, Arizona or can call on phone at 623-327-6170.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.